The Insulin Response to Glucose Test, 5 Specimens evaluates insulin secretion at fasting and multiple post-glucose solution intervals. This expanded assessment highlights beta-cell function, insulin sensitivity, and abnormalities in carbohydrate metabolism. Results offer valuable information on how the body clears glucose and help identify insulin resistance, metabolic dysfunction, and diabetes-related risks.

The Insulin Response to Glucose Test, 3 Specimens evaluates insulin secretion at three time points: fasting and after drinking a glucose solution at set intervals. This approach helps identify abnormal insulin sensitivity, altered beta-cell activity, and impaired carbohydrate metabolism. Results provide essential information about how efficiently the body regulates glucose, supporting early detection of insulin resistance or diabetes risk.

The Insulin Response to Glucose Test, 6 Specimens evaluates insulin secretion and glucose regulation with fasting and five post-glucose solution samples. This comprehensive approach highlights beta-cell activity, insulin resistance, and abnormalities in carbohydrate metabolism. Results show how efficiently the body clears glucose, supporting early detection of metabolic dysfunction, prediabetes, and diabetes risk.

The Insulin Response to Glucose Test, 4 Specimens evaluates insulin secretion and glucose regulation using fasting and three post-glucose solution samples. This expanded view highlights beta-cell activity, insulin resistance, and abnormal carbohydrate metabolism. Results reveal how efficiently the body processes glucose and help identify metabolic dysfunction, prediabetes, and diabetes-related risks.

The Insulin Response to Glucose Test, 2 Specimens evaluates insulin secretion by comparing fasting levels with those measured after drinking a glucose solution. This test helps identify impaired insulin sensitivity, abnormal glucose regulation, and early metabolic dysfunction. It provides valuable information on beta-cell function, carbohydrate metabolism, and risk of developing prediabetes or diabetes.

The Insulin Response to Glucose Test, 7 Specimens evaluates insulin secretion and glucose regulation using fasting plus six post-glucose solution samples. With seven data points, the test highlights abnormalities in beta-cell activity, insulin resistance, and carbohydrate metabolism. Results provide valuable insight into how the body processes glucose and help identify metabolic dysfunction, prediabetes, or diabetes risk.

The Insulin Response to Glucose Test, 8 Specimens evaluates insulin secretion and glucose handling using fasting and seven post-glucose solution samples. This extended assessment highlights beta-cell activity, insulin resistance, and carbohydrate metabolism. Results reveal how efficiently the body processes glucose, supporting early detection of prediabetes, diabetes, or related metabolic disorders.

The Insulin Response to Glucose Test, 9 Specimens evaluates insulin secretion and glucose regulation through fasting plus eight post-glucose solution samples. This extended assessment highlights beta-cell performance, insulin resistance, and carbohydrate metabolism. Results provide insight into how the body processes glucose and support early detection of metabolic dysfunction, prediabetes, or diabetes risk.

The Advanced Blood Sugar Monitoring - Basic Plus panel offers a more detailed look into blood sugar regulation and potential autoimmune aspects of diabetes. It includes the 3 Specimens Glucose Tolerance Test, Glutamic Acid Decarboxylase-65 Antibody, Hemoglobin A1c, and 3 Specimens Insulin Response to Glucose, providing a comprehensive evaluation of glucose metabolism and insulin function.

The Advanced Blood Sugar Monitoring - Advanced panel provides an in-depth analysis of blood sugar regulation, insulin function, and potential autoimmune aspects of diabetes. This comprehensive panel includes Adiponectin, a 4 Specimens Glucose Tolerance Test, Glutamic Acid Decarboxylase-65 Antibody, Hemoglobin A1c, and a 4 Specimens Insulin Response to Glucose test.

The Advanced Blood Sugar Monitoring - Comprehensive panel is the most extensive assessment in the series, designed to provide a detailed analysis of glucose metabolism, insulin sensitivity, and autoimmune diabetes indicators. It includes Adiponectin, a 5 Specimens Glucose Tolerance Test, Glutamic Acid Decarboxylase-65 Antibody, Hemoglobin A1c, IA-2 Antibody, a 4 Specimens Insulin Response to Glucose, and Proinsulin tests.

 The DH-4 Diabetes Health panel is a comprehensive suite of tests tailored for individuals with diabetes, particularly those with complex management needs or those at high risk for complications. This panel includes C-Reactive Protein (CRP), CBC with Differential and Platelets, Comprehensive Metabolic Panel (CMP), 2 Specimen Glucose Tolerance Test, Hemoglobin A1c, Insulin, 2 Specimen Insulin Response to Glucose, Lipid Panel, and Random Urine Microalbumin with Creatinine. It is designed to provide a thorough assessment of diabetes control, cardiovascular risk, insulin function, kidney health, and overall metabolic status.